Batches of the Oxford/AstraZeneca coronavirus vaccine have started arriving at UK hospitals ahead of the jab’s nationwide roll-out.
Some 530,000 doses of the treatment will be available for roll-out across the UK from Monday, with vulnerable groups already identified as the priority for immunisation.
The vaccine has been developed in the UK by Oxford University and the pharmaceutical giant AstraZeneca.
The roll-out will begin after England’s chief medical officer Chris Whitty warned vaccine shortages are likely to cause problems for “several months”.Advertisement
He said the UK urgently needs to maximise the number of people who are vaccinated, but added a lack of global supplies will likely hamper efforts to protect the nation in the first part of 2021.
Public Health England (PHE) has said it does not recommend mixing coronavirus vaccines from different suppliers amid fears over the possible shortages.
Both the Oxford/AstraZeneca vaccine and the Pfizer/BioNTech vaccine, which has been rolled out from December, require two doses.
The UK government had issued guidance telling NHS medics that if a person who has received their first coronavirus jab goes back for their second but the same type is not available, or the first vaccine type is unknown, then it is “reasonable” to offer a dose of another vaccine.
Dr Mary Ramsay, head of immunisations at PHE, has since told Sky News that mixing is not recommended and should only happen on “rare occasions”.
The Princess Royal Hospital in Haywards Heath, which is part of Brighton and Sussex University Hospitals NHS Trust, was one of the first hospitals to take delivery of a batch of the Oxford/AstraZeneca vaccine on Saturday morning.
First doses of the vaccine will be administered next week after the UK recorded another 57,725 coronavirus cases on Saturday – its highest ever daily total. Another 445 deaths were reported.
Dr George Findlay, chief medical officer and deputy chief executive at the trust, said the vaccination programme gives NHS staff “more confidence” coming into work.
He added hundreds of people are expected to be vaccinated per day at the Princess Royal Hospital site, with efficiency expected to increase after the first few days of the programme.
Dr Findlay said the Oxford/AstraZeneca vaccine, which can be kept at normal fridge temperature, is “much easier” to administer when compared with the jab from Pfizer and BioNTech, which needs cold storage of around minus 70C.
More than a million people have already received the first of two jabs of the Pfizer/BioNTech vaccine.
Second doses of either vaccine will now take place within 12 weeks rather than the 21 days that was initially planned with the Pfizer/BioNTech jab, following a change in guidance which aims to accelerate immunisation.
Doctors’ Association UK (DAUK) has raised concerns over the spacing of the second dose of the Pfizer vaccine and what it calls “the lack of a coherent strategy for the current crisis”.
Dr Natalie Ashburner, vice-chair of DAUK, said: “Poor communication and lack of engagement with frontline clinicians who are implementing this vaccine programme and dealing with the NHS pressures has led us to this point.
“Moving forward we urge a rapid reassessment of the strategy as a whole with a clear plan that has had frontline clinician input, so that even if we are deviating from certain guidelines, we are doing so together and with the backing of the science.”
Dr Vinesh Patel, from the GP committee of DAUK, said: “There are a great many concerns that the change in vaccine strategy and dosing regimen has been communicated poorly and represents an attempt to stem public health failings.
“There appears to have been little to no involvement with frontline clinicians in making this decision, and subsequently chaos is ensuing…. (the change in strategy) is a huge gamble, and one made without the data to back this strategy.”
The full article can be accessed here: https://news.sky.com/story/covid-19-batches-of-oxford-astrazeneca-coronavirus-vaccine-arrive-at-uk-hospitals-ahead-of-roll-out-12177510
